Effect of resveratrol on peritoneal macrophages in rats with severe acute pancreatitis

Inflammation Research

Volumn 54, Issue 12, 2005, Pages 522-527

  Ma, Z H ^a   Ma, Q Y ^a   Wang, L C ^a   Sha, H C ^a   Wu, S L ^a   Zhang, M ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Macrophages; Pancreatitis; Resveratrol

Indexed keywords

ANTIINFLAMMATORY AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; NITRIC OXIDE; RESVERATROL; TAUROCHOLIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PANCREATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HISTOLOGY; INCUBATION TIME; INFLAMMATION; INHIBITION KINETICS; MALE; NONHUMAN; PANCREAS DUCT; PERITONEUM MACROPHAGE; PROTEIN EXPRESSION; RAT;

ACUTE DISEASE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CULTURE MEDIA; DISEASE MODELS, ANIMAL; INTERLEUKIN-1; MACROPHAGES, PERITONEAL; MALE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PANCREATITIS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 29944444280     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-005-1388-z     Document Type: Article

References (36)

1. Puneet P, Moochhala S, Bhatia M. Chemokines in acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2005; 288: L3-L15.
2. Hirota M, Sugita H, Maeda K, Ichibara A, Ogawa M. The concept of SIRS and severe acute pancreatitis. Nippon Rinsho 2004; 62: 2128-2136.
3. Raraty MG, Connor S, Criddle DN, Sutton R, Neoptolemos JP. Acute pancreatitis and organ failure: pathophysiology, natural history, and management strategies. Curr Gastroenterol Rep 2004; 6: 99-103.
4. Yu WK, Li WQ, Li N, Li JS. Impact factors and clinical significance of the lung injury complicating acute pancreatitis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2004; 16: 100-102.
5. Makhija R, Kingsnorth AN. Cytokine storm in acute pancreatitis. J Hepatobiliary Pancreat Surg 2002; 9: 401-410.
6. Dugernier T, Reynaert M, Laterre PF. Early multi-system organ failure associated with acute pancreatitis: a plea for a conservative therapeutic strategy. Acta Gastroenterol Belg 2003; 66: 177-183.
7. Dugernier TL, Laterre PF, Wittebole X, Roeseler J, Latinne D, Reynaert MS, et al. Compartmentalization of the inflammatory response during acute pancreatitis: correlation with local and systemic complications. Am J Respir Crit Care Med 2003; 168: 148-157.
8. Chen X., Wu H, Huang X, Wu X. The alteration of inflammatory cytokine during acute pancreatitis. Hua Xi Yi Ke Da Xue Xue Bao 2002; 33: 238-240, 243.
9. Zhang Q, Ni Q, Cai D, Zhang Y, Zhang N, Hou L. Mechanisms of multiple organ damages in acute necrotizing pancreatitis. Chin Med J (Engl) 2001; 114: 738-742.
10. Tadao M, Yuji O. Role of free radicals in the development of severe acute pancreatitis. Nippon Rinsho 2004; 62: 2015-2020.
11. Liu HS, Pan CE, Liu QG, Yang W, Liu XM. Effect of NF-kappaB and p38 MAPK in activated monocytes/macrophages on pro-inflammatory cytokines of rats with acute pancreatitis. World J Gastroenterol 2003; 9: 2513-2518.
12. Mikami Y, Takeda K, Shibuya K, Qiu-Feng H, Shimamura H, Yamauchi J, et al. Do peritoneal macrophages play an essential role in the progression of acute pancreatitis in rats? Pancreas 2003; 27: 253-260.
13. Sakai Y, Masamune A, Satoh A, Nishihira J, Yamagiwa T, Shimosegawa T. Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis. Gastroenterology 2003; 124: 725-736.
14. Cheng S, He S, Zhang J. The role of alveolar macrophage activation in rats with lung injury associated with acute necrotizing pancreatitis. Zhonghua Wai Ke Za Zhi 2002; 40: 609-612.
15. Takeyama Y, Nishikawa J, Ueda T, Hori Y, Yamamoto M, Kuroda Y. Involvement of peritoneal macrophage in the induction of cytotoxicity due to apoptosis in ascitic fluid associated with severe acute pancreatitis. J Surg Res 1999; 82: 163-171.
16. Closa D, Sabater L, Fernandez-Cruz L, Prats N, Gelpi E, Rosello-Catafau J. Activation of alveolar macrophages in lung injury associated with experimental acute pancreatitis is mediated by the liver. Ann Surg 1999; 229: 230-236.
17. Leindler L, Morschl E, Laszlo F, Mandi Y, Takacs T, Jarmai K, et al. Importance of cytokines, nitric oxide, and apoptosis in the pathological process of necrotizing pancreatitis in rats. Pancreas 2004; 29: 157-161.
18. Gomez-Cambronero LG, Sabater L, Pereda J, Cassinello N, Camps B, Vina J, et al. Role of cytokines and oxidative stress in the pathophysiology of acute pancreatitis: therapeutical implications. Curr Drug Targets Inflamm Allergy 2002; 1: 393-403.
19. Grewal HP, Kotb M, Din AM, Ohman M, Salem A, Gaber L, et al. Induction of tumor necrosis factor in severe acute pancreatitis and its subsequent reduction after hepatic passage. Surgery 1994; 115: 213-221.
20. Powell JJ, Fearon KC, Siriwardena AK, Ross JA. Evidence against a role for polymorphisms at tumor necrosis factor.interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis. Surgery 2001; 129: 633-640.
21. Mayer J, Rau B, Gansauge F, Beger HG. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 2000; 47: 546-552.
22. Leiro J, Alvarez E, Garcia D, Orallo F. Resveratrol modulates rat macrophage functions. Int Immunopharmacol 2002; 2: 767-774.
23. Huang JY, Ma QY, Sun Q, Liu XM, Xu J. Experimental study of resveratrol on severe acute pancreatitis. Journal of Xi'an Jiaotong University (Medical Science) 2005; 26: 163-165.
24. Schreiber E, Matthias P, Müller MM, Schaffner W. Rapid detection of octamer binding protein with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res 1989; 17: 6419
25. Schmidt J, Lewandrowsi K, Warshaw AL, Compton CC, Rattner DW. Morphometric characteristics and homogeneity of a new model of acute pancreatitis in the rat. Int J Pancreatol 1992; 12: 41-51.
26. Masamune A, Shimosegawa T. Anti-cytokine therapy for severe acute pancreatitis. Nippon Rinsho 2004; 62: 2116-2121.
27. Zhou ZG, Chen YD. Influencing factors of pancreatic microcirculatory impairment in acute panceatitis. World J Gastroenterol 2002; 8: 406-412.
28. Han SJ, Ko HM, Choi JH, Seo K.H, Lee HS, Choi EK, et al. Molecular mechanisms for lipopolysaccharide-induced biphasic activation of nuclear factor-kappa B (NF-kappa B). J Biol Chem 2002;277: 44715-44721.
29. Suyuki K, Ichinowatari G, Tanimoto A, Yamada M, Yaginuma H, Ohuchi K. Possible participation of intracellular platelet-activating factor in NF-kappa B activation in rat peritoneal macrophages. Biochim Biophys Acta 2002; 1583: 26-34.
30. Huang KC, Chen CW, Chen JC, Lin WW. HMG-CoA Reductase Inhibitors Inhibit Inducible Nitric Oxide Synthase Gene Expression in Macrophages. J Biomed Sci 2003; 10: 396-405.
31. Hense S, Sparmann G, Weber H, Liebe S, Emmrich J. Immunologic characterization of acute pancreatitis in rats induced by dibutyltin dichloride (DBTC). Pancreas 2003; 27: e6-e12.
32. Akhmad AR. Immune disorders in patients with acute pancreatitis in postoperative period. Klin Khir 2002; 10: 15-6.
33. Yamaguchi Y, Matsumura F, Liang J, Okabe K, Matsuda T, Ohshiro H, et al. Platelet-activating factor antagonist (TCV-309) attenuates the priming effects of bronchoalveolar macrophages in cerulein-induced pancreatitis rats. Pancreas 1999; 18: 355-363.
34. Olas B, Wachowicz B. Biological activity of resveratrol. Postepy Hig Med Dosw 2001; 55: 71-79.
35. Bhat KPL, Kosmeder JW 2nd, Pezzuto JM. Biological effects of resveratrol. Antioxid Redox Signal. 2001; 3(6): 1041-1064.
36. Baolin L, Inami Y, Tanaka H, Inagaki N, Iinuma M, Nagai H. Resveratrol inhibits the release of mediators from bone marrow-derived mouse mast cells in vitro. Planta Med 2004; 70: 305-309.